Journal articleJ Immunother Cancer2022
Insufficiency of compound immune checkpoint blockade to overcome engineered T cell exhaustion in pancreatic cancer.
- Journal
- J Immunother Cancer
- Published
- 1 February 2022
- Citations
- 13
- Type
- Article
- License
- cc by-nc
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Grants 5
- OVERCOMING STROMAL BARRIERS TO THERAPEUTICS IN PANCREAS CANCER R01CA161112↗
- Mechanisms of immunotherapy response and resistance in pancreatic ductal adenocarcinoma R01CA249393↗
- Enhancing engineered T cell therapeutic efficacy for the treatment of pancreatic ductal adenocarcinoma R01CA255039↗
- MyD88 fusion protein with antigen specific T Cell therapy for enhanced response in solid tumors R43CA254794↗
- Stopping PDA progression using inhibitors of CSC dissemination and immunotherapy U01CA224193↗